Related Experiment Videos
Changes in bone mineral density and bone-specific alkaline phosphatase in ovariectomized ewes
1Department of Clinical Sciences, Colorado State University, Ft. Collins 80523, USA.
Bone
|October 1, 1995
Summary
The ovariectomized ewe model shows potential for osteoporosis research, with vertebral bone mineral density decreasing six months post-surgery. This model may aid in testing new osteoporosis therapies.
Area of Science:
- Veterinary Medicine
- Endocrinology
- Bone Biology
Background:
- Developing an adequate animal model for human osteoporosis is crucial for testing new therapeutic agents.
- The aged ewe presents a potential model due to observed bone remodeling changes within three months and bone mass differences six months post-ovariectomy.
Purpose of the Study:
- To evaluate longitudinal changes in bone mass and bone-specific alkaline phosphatase (BSAP) over six months in ovariectomized (OVX) ewes.
- To assess the suitability of the aged ewe as an animal model for human osteoporosis.
Main Methods:
- Thirty 7-9 year old ewes were divided into sham-treated, OVX, and OVX with estrogen implants (OVXE) groups.
- Bone mineral density (BMD) was measured at the vertebrae, calcaneus, and distal radius using dual-energy X-ray absorptiometry (DEXA) at baseline, 3, and 6 months.
- Bone-Specific Alkaline Phosphatase (BSAP) was measured monthly.
Main Results:
- Vertebral BMD (L4-L6/L5-L7) was significantly lower in the OVX group compared to the sham group (p < 0.08) after six months.
- No significant changes in BMD were observed in the calcaneus or distal radius.
- Ovariectomy was confirmed by increased luteinizing hormone, and estrogen implants increased uterine weight.
Conclusions:
- The ovariectomized ewe model demonstrates a significant decrease in vertebral bone mineral density, indicating its potential for studying osteoporosis.
- This model may be suitable for evaluating therapeutic agents aimed at treating postmenopausal osteoporosis.
- Further research is warranted to fully validate this model for preclinical osteoporosis studies.